Zvast-Bio Preclinical service z-bo 2020-12-16 1259

　　On December 15, 2020, Liang Guiqiu, the legal person chairman of Shenzhen Glory Medical Co., Ltd., visited Jiang Bin, general manager of Zvast-Bio, and the two parties had in-depth exchanges on topics related to corporate development.

　　General Manager Jiang Bin firstly thanked Chairman Liang Guiqiu for coming to Zvast-Bio from Shenzhen for a special visit. Mr. Jiang gave a detailed introduction to Chairman Liang Guiqiu on Zvast-Bio’s industry track CRO services and life science services. Subsequently, the two parties discussed the four topics of Zvast-Bio’s profit model, personnel structure, customer needs and gross profit margin. Chairman Liang Guiqiu recognized Zvast-Bio’s industry track and how fast, better, and more economical development model. Cooperate in the promotion of listing.

　　Before the negotiation between the two parties, Dr. Yuan Yongming, Director of Research and Development of Zvast-Bio, led Chairman Liang Guiqiu to visit the laboratory scientific research platform and showed the development history of Zvast-Bio.

　　 It is understood that Shenzhen Glory Medical Co., Ltd.. was founded in 1998 and was listed on the main board of the Shenzhen Stock Exchange in February 2011. After more than 20 years of deep cultivation in the industry, the company has provided thousands of hospitals with overall solutions for modern hospital construction, and has accumulated rich experience, Professional talents, core technology, application software and the best industry solutions.